We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
THAR

Price
2.97
Stock movement down
-0.03 (-1.00%)
Company name
Tharimmune Inc.
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
20.22M
Ent value
-
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
50.00%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-10-30

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

THAR does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash2.24M
Net receivables0.00
Total current assets2.53M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets2.53M
Accounts payable770.61K
Short/Current long term debt249.72K
Total current liabilities2.16M
Total liabilities2.16M
Shareholder's equity0.00
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open3.00
Daily high3.05
Daily low2.95
Daily Volume112K
All-time high1537.50
1y analyst estimate5.00
Beta1.44
EPS (TTM)-
Dividend per share0.00
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
THARS&P500
Current price drop from All-time high-99.81%-1.10%
Highest price drop-99.93%-19.00%
Date of highest drop9 Apr 20258 Apr 2025
Avg drop from high-99.86%-2.76%
Avg time to new high-5 days
Max time to new high266 days89 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
THAR (Tharimmune Inc.) company logo
Marketcap
20.22M
Marketcap category
Small-cap
Description
Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for immunology and inflammation conditions in the United States. It is involved in the development of TH104 for the proposed indication of temporary prophylaxis of respiratory and/or nervous system depression in military personnel and chemical incident responders entering and area contaminated with opioids, as well as is in phase 2 study in patients with chronic pruritus in primary biliary cholangitis. The company also engages in the development of TH023 to treat autoimmune indications; and HS1940, a bispecific biologic against PD-1 and vascular endothelial growth receptor antibody that targets both receptors. It has a research collaboration and product license agreement with Minotaur Therapeutics, Inc. for the development of proprietary targeted biologics. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was incorporated in 2017 and is based in Red Bank, New Jersey.
Employees
2
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...